Literature DB >> 11241409

E-cadherin gene mutations in human intrahepatic cholangiocarcinoma.

K Endo1, K Ashida, N Miyake, T Terada.   

Abstract

Deletions or mutations of the E-cadherin gene may result in reduced cell adhesiveness. In particular, conservative point mutations within the N-terminal calcium-binding pocket (including exons 7, 8, and 9) are frequently detected in several cancers and are enough to abolish cell-cell adhesion. There have been no studies on E-cadherin gene mutations in human intrahepatic cholangiocarcinoma (ICC). Human ICCs were therefore investigated for E-cadherin gene mutations within exons 7, 8, and 9. In addition, the relationships were analysed between their mutations and the immunohistochemical expression of E-cadherin, histological grade, and clinicopathological parameters. The E-cadherin gene was analysed in 34 tumours by nested polymerase chain reaction/single-strand conformation polymorphism (PCR/SSCP) followed by DNA sequencing. In four of the 34 cases (11.8%), tumour-restricted mobility shifts were observed; two cases harboured a single shift, one case presented two different mobility shifts, and one case presented three different mobility shifts within exons 7 and 8, encoding extracellular domains of E-cadherin. Polymorphism as previously reported was not identified and all seven new DNA alterations were not present in genomic DNA of non-tumour origin. The E-cadherin gene mutations correlated significantly with down-regulated E-cadherin protein expression and high ICC histological grade. These data suggest that E-cadherin gene mutations in ICC are associated with reduced cell adhesiveness and high histological grade.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11241409     DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH816>3.0.CO;2-K

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  12 in total

Review 1.  Involvement of members of the cadherin superfamily in cancer.

Authors:  Geert Berx; Frans van Roy
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-09-23       Impact factor: 10.005

Review 2.  Recent advances in the regulation of cholangiocarcinoma growth.

Authors:  Heather Francis; Gianfranco Alpini; Sharon DeMorrow
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-04-29       Impact factor: 4.052

Review 3.  Molecular diagnosis of intrahepatic cholangiocarcinoma.

Authors:  Hiroaki Haga; Tushar Patel
Journal:  J Hepatobiliary Pancreat Sci       Date:  2014-09-29       Impact factor: 7.027

Review 4.  Genetic profiling of intrahepatic cholangiocarcinoma.

Authors:  Jesper B Andersen; Snorri S Thorgeirsson
Journal:  Curr Opin Gastroenterol       Date:  2012-05       Impact factor: 3.287

5.  E-cadherin gene mutations frequently occur in synovial sarcoma as a determinant of histological features.

Authors:  T Saito; Y Oda; K Sugimachi; K Kawaguchi; S Tamiya; K Tanaka; S Matsuda; A Sakamoto; Y Iwamoto; M Tsuneyoshi
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

Review 6.  Cholangiocarcinoma: modern advances in understanding a deadly old disease.

Authors:  Harmeet Malhi; Gregory J Gores
Journal:  J Hepatol       Date:  2006-09-25       Impact factor: 25.083

Review 7.  Genetic and epigenetic changes associated with cholangiocarcinoma: from DNA methylation to microRNAs.

Authors:  Monique Stutes; Steven Tran; Sharon DeMorrow
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

8.  Patterns of chromosomal copy-number alterations in intrahepatic cholangiocarcinoma.

Authors:  Cyril Dalmasso; Wassila Carpentier; Catherine Guettier; Sophie Camilleri-Broët; Wyllians Vendramini Borelli; Cedália Rosane Campos Dos Santos; Denis Castaing; Jean-Charles Duclos-Vallée; Philippe Broët
Journal:  BMC Cancer       Date:  2015-03-14       Impact factor: 4.430

Review 9.  The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer.

Authors:  Abigail Zabron; Robert J Edwards; Shahid A Khan
Journal:  Dis Model Mech       Date:  2013-03       Impact factor: 5.758

10.  Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma.

Authors:  Mitesh J Borad; Mia D Champion; Jan B Egan; Winnie S Liang; Rafael Fonseca; Alan H Bryce; Ann E McCullough; Michael T Barrett; Katherine Hunt; Maitray D Patel; Scott W Young; Joseph M Collins; Alvin C Silva; Rachel M Condjella; Matthew Block; Robert R McWilliams; Konstantinos N Lazaridis; Eric W Klee; Keith C Bible; Pamela Harris; Gavin R Oliver; Jaysheel D Bhavsar; Asha A Nair; Sumit Middha; Yan Asmann; Jean-Pierre Kocher; Kimberly Schahl; Benjamin R Kipp; Emily G Barr Fritcher; Angela Baker; Jessica Aldrich; Ahmet Kurdoglu; Tyler Izatt; Alexis Christoforides; Irene Cherni; Sara Nasser; Rebecca Reiman; Lori Phillips; Jackie McDonald; Jonathan Adkins; Stephen D Mastrian; Pamela Placek; Aprill T Watanabe; Janine Lobello; Haiyong Han; Daniel Von Hoff; David W Craig; A Keith Stewart; John D Carpten
Journal:  PLoS Genet       Date:  2014-02-13       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.